Why the 40:1 Inositol Ratio Matters (And Why Most Supplements Skip It)

Most articles about inositol talk about the dose. The dose is half the story. The other half — the part the supplement industry quietly skips — is the ratio.

If you've read anything about inositol supplements for hormonal balance, you've probably seen the 40:1 ratio mentioned. Sometimes it's a marketing tagline. Sometimes it's a footnote in clinical research. Rarely is it explained properly — what it actually is, why it matters, where it came from, and what happens to a supplement that ignores it.

This article is the explanation. Same framework we use when we formulate Belle Balance at the 4,000mg dose and the 40:1 ratio: read the research, match the formulation to the trials, don't borrow credibility from studies the bottle doesn't reflect.

What is the 40:1 ratio in inositol supplements?

Inositol isn't a single substance. It's a family of nine related compounds called stereoisomers — same molecular formula, different three-dimensional arrangements. Two of them matter for hormonal health: myo-inositol (MI) and D-chiro-inositol (DCI).

In healthy women's plasma, these two isomers occur naturally at a ratio of roughly 40 parts myo to 1 part D-chiro. That's where the 40:1 figure comes from. It's not a marketing invention — it's the body's own balance.

When a supplement says "40:1 inositol," it means: for every 4,000mg of myo-inositol, there's 100mg of D-chiro-inositol. That mirrors the plasma ratio the body maintains naturally, which is also the ratio the largest body of clinical research has used.

When a supplement says "inositol" without specifying a ratio, one of three things is true: it contains myo-inositol alone, it contains a different (often unstudied) ratio, or it's a proprietary blend that hides the breakdown. None of these match the 40:1 research.

Why the ratio matters more than the total dose

The instinctive assumption with supplements is that more is better. With inositol, the picture is more nuanced — because myo-inositol and D-chiro-inositol do different jobs.

Myo-inositol is the predominant form in healthy ovarian tissue. It's involved in follicle-stimulating-hormone signalling, glucose metabolism, and the formation of secondary messengers that respond to insulin. D-chiro-inositol, by contrast, is involved in glucose-related pathways but at much lower physiological concentrations — particularly in the ovaries.

The body converts a small amount of myo into D-chiro as needed, regulated by an enzyme called epimerase. In healthy ovarian tissue, that conversion stays low — preserving the 40:1 balance. In some women, particularly those with insulin resistance, the epimerase becomes overactive, converting too much myo to D-chiro and depleting ovarian myo-inositol — the form the ovaries actually need.

This means two things. First: total inositol isn't the right measure. Form-specific concentrations matter. Second: a supplement that floods the system with D-chiro doesn't correct an imbalance — in some cases, it can worsen the one that already exists.

The total dose number on the label tells you the supplement contains inositol. The ratio tells you whether the formulation reflects how the body actually uses it.

The D-chiro paradox: when more inositol is harmful

This is the part of the inositol story the supplement category tends to skim over: more D-chiro-inositol can make things worse, not better.

It sounds counterintuitive — but it's well-documented in the research. A 2020 paper led by Bevilacqua and colleagues, titled "Inositol Treatment for PCOS Should Be Science-Based and Not Arbitrary," catalogued the published evidence on what happens when D-chiro-inositol is delivered at supraphysiological doses (above the body's natural balance). The findings show that excess D-chiro can impair oocyte quality, disrupt ovulatory signalling, and reduce ovarian myo-inositol availability — the opposite of what most buyers expect from an "inositol supplement."

The mechanism is straightforward. The ovaries depend on a high myo-to-D-chiro ratio to function normally. When supplementation tips the balance the wrong way, the ovaries are forced to operate in a chemical environment they aren't designed for. The supplement industry's "more is better" instinct doesn't apply.

This is why the 40:1 ratio is conservative by design. It mirrors what the body itself maintains. Supplements that contain D-chiro at ratios like 1:1, 5:1, or 10:1 — sometimes marketed as "balanced formulations" — deliver substantially more D-chiro than the body's plasma carries. They are above physiological balance, not at it.

The 40:1 ratio isn't a marketing target. It's the upper bound of D-chiro the body tolerates without changing ovarian chemistry.

Where the 40:1 number comes from

The 40:1 ratio entered clinical research in the late 2000s. Italian endocrinology research first established that healthy women's plasma contained myo and D-chiro inositol at this approximate ratio, and proposed it as the physiological reference point for supplementation.

The 2014 International Consensus Conference in Florence on the use of myo and D-chiro inositol in obstetrics and gynaecology formally affirmed the 40:1 ratio as the basis for clinical use. Subsequent trials — and the major meta-analyses that aggregated them — used this ratio as standard.

The most-cited modern reference is the 2017 meta-analysis by Unfer and colleagues, which aggregated randomised controlled trials of myo-inositol — many at the 40:1 ratio with D-chiro — and found measurable effects on menstrual cycle regularity and metabolic markers in women with hormonal imbalance. This meta-analysis is the citation most modern inositol supplements implicitly reference, whether or not their formulations actually match it.

The point of the history matters: the 40:1 ratio isn't an arbitrary product specification. It's the only inositol ratio with substantial randomised controlled trial backing. Any product that says "inositol" without specifying a ratio is, at best, riding on research that was conducted on a different formulation.

(For the broader framework on how supplement labels and research diverge, see our piece on what "clinical dose" actually means.)

How UK inositol supplements compare to the 40:1 standard

The simplest way to see how the UK supplement category handles the 40:1 ratio is to lay the labels out side by side. Every figure below is taken from product pages or labels as published; we've kept the comparison to verifiable facts only.

Two patterns emerge. First, sachet-format inositol products tend to cluster around 2,000mg total — half the dose used in the meta-analyses. Second, of the UK products that do include both isomers, the ratios diverge significantly from 40:1: Wellgard's 111:1 is heavily myo-dominant with a small D-chiro inclusion, which puts the product closer to a myo-only formulation in practice than to a clinical 40:1 match.

For a buyer comparing labels by ingredient name alone, all five of these products contain "inositol." For a buyer reading them through the framework above, they are five quite different formulations.

If you're specifically looking for an Ovasitol equivalent in the UK, we compare what's available in Ovasitol in the UK: availability and the best alternatives.

Three things to check on any inositol supplement label

If you want to evaluate an inositol supplement in under a minute, three checks are enough.

1. Are both isomers listed separately? A label that says only "inositol 2,000mg" tells you nothing about which form or ratio is used. A label that names myo-inositol and D-chiro-inositol with separate amounts is at least transparent.

2. What's the daily total of myo-inositol? The clinical research the inositol category rests on uses 4,000mg of myo-inositol daily. Anything substantially below that is a different dose with its own (smaller) evidence base — not the meta-analysis-supported dose buyers usually have in mind.

3. Divide myo by D-chiro. Is the answer close to 40? 40:1 is the physiological balance. Ratios under 20:1 deliver more D-chiro than the body's natural plasma carries. Ratios over 60:1 are functionally myo-only, missing the D-chiro half of the formulation the research used.

Three checks. About forty seconds of label-reading. The category divides cleanly between products that pass all three and products that don't. Once you've picked one, when and how to take it is the next practical question.

Not every "inositol" on a label is the same molecule, either. We break down the forms — and why "DC95" isn't D-chiro at all — in myo-inositol vs D-chiro-inositol vs DC95.

One Last Thought

The 40:1 ratio is one of those details that looks pedantic until you realise it's load-bearing. The clinical research on inositol for women's hormonal wellness was built on this specific balance — and supplements that ignore it are quietly carrying the research's credibility without carrying its formulation.

The label says "inositol." The ratio decides whether the bottle reflects the research or just borrows its name.

Frequently Asked Questions

What does 40:1 mean in inositol supplements?

The 40:1 ratio refers to myo-inositol and D-chiro-inositol — two forms of inositol that occur naturally together in healthy women's plasma at this specific balance. Most clinical research on inositol for hormonal wellness uses this ratio because it mirrors the body's own balance, rather than swamping the system with either form.

Why does the inositol ratio matter more than the total dose?

Myo-inositol and D-chiro-inositol have different roles in the body, and they're not interchangeable. Research has shown that supraphysiological D-chiro doses can impair ovarian function, while myo-inositol alone is missing part of the picture the larger trials studied. The ratio is what makes the published research apply to a given supplement.

Is myo-inositol alone enough, or do I need D-chiro-inositol too?

Myo-inositol alone has its own (smaller) research base. But the larger body of clinical research — the meta-analyses and trials supporting menstrual cycle regularity — used the 40:1 myo-to-D-chiro combination. If you're buying inositol because of that research, the 40:1 ratio is what you're matching against on the label.

What ratio of myo and D-chiro inositol is used in PCOS research?

The 40:1 ratio is the most-studied ratio in PCOS-related inositol research. It reflects the natural plasma balance in healthy women and was formally affirmed at the 2014 International Consensus Conference in Florence. The 2017 Unfer et al. meta-analysis of randomised controlled trials used this ratio across its included studies.

Can too much D-chiro-inositol be harmful?

Research published in 2020 by Bevilacqua and colleagues documented that supraphysiological doses of D-chiro-inositol can impair ovarian function — the opposite of the effect inositol is reputed to support. Higher D-chiro is not better. The 40:1 ratio specifically avoids this by keeping D-chiro at the natural plasma balance.

How can I tell if an inositol supplement uses the 40:1 ratio?

Check the label for both myo-inositol AND D-chiro-inositol with their separate amounts listed. If only myo is named, there's no ratio. If both are listed, divide the myo amount by the D-chiro amount. 40:1 means roughly 100mg D-chiro per 4,000mg myo. Different ratios point to different formulations entirely.

---